What's Happening?
The International Organization for Standardization (ISO) has officially approved 'tomovircona' as the common name for a new RNA interference (RNAi)-based virucide developed by Silicon Gene Technologies. This approval follows a public consultation process
with no objections. Tomovircona targets plant viruses with high specificity, representing a new generation of crop protection technologies. The active ingredient, registered under CAS No. 3052205-09-8, works by silencing specific genes involved in disease development, offering targeted disease management while minimizing impacts on non-target organisms.
Why It's Important?
The approval of tomovircona as a common name marks a significant advancement in agricultural biotechnology. RNAi-based technologies offer a promising approach to managing plant diseases, potentially reducing the need for traditional chemical pesticides. This can lead to more sustainable agricultural practices, benefiting both the environment and the agricultural industry. The development of such targeted solutions is crucial as global agriculture faces challenges from climate change and the need to increase food production sustainably.
